[Federal Register Volume 64, Number 191 (Monday, October 4, 1999)] [Notices] [Pages 53680-53681] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-25683] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [INFO-99-43] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506 (c) (2) (A) of the Paperwork reduction Act of 1995, the Center for Disease Control and Prevention is providing opportunity for public comment on proposed data collection projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) The accuracy of the agency's estimate of the burden of the [[Page 53681]] proposed collection of information; (c) Ways to enhance the quality, utility, and clarity of the information to be collected; and (d) Ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice. Proposed Projects Multi-Center Cohort Study to Assess the Risk and Consequences of Hepatitis C Virus Transmission from Mother to Infant (0920-0344)-- Renewal--The National Center for Infectious Diseases (NCID)--The purpose of the proposed study is (1) To determine the incidence of vertical hepatitis C virus (HCV) transmission, (2) To assess risk factors for vertical HCV transmission, (3) To assess the clinical course of disease among infants with HCV infection, and (4) To assess diagnostic methods for detecting HCV infection in infants. HCV is a blood-borne pathogen and is the major etiologic agent of what was previously referred to as parenterally-transmitted non-A, non-B hepatitis. Diagnostic tests for HCV infection have recently been developed and HCV has been demonstrated to account for about 20% of all cases of viral hepatitis in the United States. Virtually all adults with acute HCV infection may become chronically infected and 50%-60% may develop chronic liver disease with persistently elevated liver enzymes. Of adults with chronic liver disease, 30%-60% may develop chronic active hepatitis and 5%-20% may develop cirrhosis within five years after illness onset. HCV is also a major contributing cause of hepatocellular carcinoma. An estimated 8,000-10,000 chronic liver disease deaths per year in the United States are attributable to HCV infection. There are no costs to respondents other than their time to participate. ---------------------------------------------------------------------------------------------------------------- Burden hours Form name No. of No. responses per Total burden respondents per respondent respondent hours ---------------------------------------------------------------------------------------------------------------- Form A.......................................... 300 1 0.25 75 Form B.......................................... 1200 1 0.25 300 Form C.......................................... 300 1 0.10 30 Form E.......................................... 300 1 0.25 75 Form G.......................................... 300 8 0.10 240 --------------------------------------------------------------- Total....................................... .............. .............. .............. 720 ---------------------------------------------------------------------------------------------------------------- 2. Chronic Fatigue Syndrome (CFS) Surveillance and Related Studies, Prevalence and Incidence of Fatiguing Illness in Sedgewick County, Kansas (0920-0401)--Renewal--The National Center for Infectious Diseases (NCID)--A Population-Based CFS Study was done previously in Kansas in 1997. Data from this cross-sectional, random-digit-dial survey of prolonged fatiguing illness in Wichita, Kansas will be added to the data previously obtained during the past 24-months from this population. The proposed study continues the Sedgwick County study using identical methodology and data collection instruments. Beginning with a random-digit-dial telephone survey to identify previously identified fatigued and non-fatigued individuals, followed by a detailed telephone interview to obtain additional data on participants' health status during the last 12-month period. Study objectives remain to refine estimates of CFS in Wichita, identify similarities and differences among fatigued and non-fatigued subjects and to describe the clinical course of fatiguing illness in this population. ---------------------------------------------------------------------------------------------------------------- No. of Average burden/ Respondents No. of responses/ respondent Total burden respondents respondent (in hrs.) (in hrs.) ---------------------------------------------------------------------------------------------------------------- Individuals screened............................ 4,500 1 0.083 374 Individuals interviewed......................... 4,500 1 0.25 1,125 --------------------------------------------------------------- Total....................................... .............. .............. .............. 1,499 ---------------------------------------------------------------------------------------------------------------- Nancy Cheal, Acting Associate Director for Policy, Planning, and Evaluation, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-25683 Filed 10-1-99; 8:45 am] BILLING CODE 4163-18-P